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T cells-6) is a ubiquitous betaherpesvirus that predominantly infects and replicates in
CD4+ T lymphocytes. However, the mechanism of HHV-6 transmission to T cells from the peripheral mucosa
is unknown. Here we found that dendritic cells (DCs) can transmit HHV-6 to T cells, resulting in productive
infection. In immature monocyte-derived DCs (MDDCs) infected with HHV-6, viral early and late antigens
were expressed, and nucleocapsids containing a DNA core were observed, although few virions were
detected in the cytoplasm by electron microscopy, indicating that the maturation of HHV-6 virions may be
incomplete in MDDCs. However, HHV-6 transmission from MDDCs to stimulated CD4+ T cells occurred
efﬁciently in coculture of these cells, but not from MDDCs culture supernatants. This transmission was
partially inhibited by treating the DCs with a viral DNA synthesis blocker, indicating that viral replication in
MDDCs is required for this transmission. Furthermore, myeloid DCs and plasmacytoid DCs infected with
HHV-6 could also transmit the virus to stimulated T cells. Thus, DCs may be the ﬁrst cell population targeted
by HHV-6 and could play an important role in the virus' transmission to T cells for their further propagation.
© 2008 Elsevier Inc. All rights reserved.Introduction
Human herpesvirus 6 (HHV-6) is a ubiquitous betaherpesvirus
that was ﬁrst isolated in 1986 from the peripheral blood of
patients with lymphoproliferative disorders (Salahuddin et al.,
1986) and AIDS (Josephs et al., 1986; Tedder et al., 1987), and
was shown to cause exanthem subitum in 1988 (Yamanishi et al.,
1988). The virus has a tropism for immune cells, e.g., CD4+ T-
lymphocytes (Lusso et al., 1988; Takahashi et al., 1989), monocytes
(Kondo et al., 1991; Niiya et al., 2006), macrophages (Kondo et al.,
1991), natural killer cells (Lusso et al., 1993), and dendritic cells
(DCs) (Asada et al., 1999; Hirata et al., 2001; Kakimoto et al., 2002;
Niiya et al., 2004), and exerts variable immunosuppressive effects
through them. HHV-6 is reported to latently infect cells of the
monocyte/macrophage lineage (Kondo et al., 1991) and bone-
marrow progenitor cells (Luppi et al., 1999), and to be reactivated
in immunocompromised patients and transplant recipients, result-
ing in a range of clinical diseases, including encephalitis or
encephalopathy (Drobyski et al., 1994; Rieux et al., 1998; Saeki et
al., 1999), interstitial pneumonitis (Buchbinder et al., 2000; Cone etccinology, National Institute of
567-0085, Japan. Fax: +81 72
l rights reserved.al., 1993), fulminant hepatitis (Asano et al., 1990; Mendel et al.,
1995), bone-marrow suppression (Carrigan and Knox, 1994;
Drobyski et al., 1993), and CMV disease (DesJardin et al., 2001,
1998).
Immature DCs patrol the peripheral tissues to capture foreign
antigens or pathogens via phagocytic or endocytic receptors. They
capture antigens, transport them to the secondary lymphoid nodes
(LN), and present processed antigens to naive T cells to initiate the
adaptive immune response. DCs are thought to play a pivotal role in
the pathogenesis of HHV-6 infection and to be involved in the
immunosuppressive effects accompanying and following acute
HHV-6 infection (Hirata et al., 2001; Kakimoto et al., 2002; Niiya
et al., 2004; Smith et al., 2005). On the other hand, DCs are
abundant in the tracheal epithelium, where HHV-6 can enter, and
therefore might be responsible for the transport of virus to
lymphoid organs and the subsequent transmission of virus to T
cells, similar to the role of DCs in human immunodeﬁciency virus
type 1 (HIV-1) transmission.
Here we identiﬁed DCs as a novel transporter of HHV-6 to CD4+
T cells. Viral early and late antigens were expressed in DCs infected
with HHV-6, and viral DNA synthesis also occurred in them,
although mature virions were scarce in the cytoplasm. However,
viral transmission from DCs to T cells was efﬁcient, while little
transmission was observed from monocyte-derived macrophages.
These data indicate that DCs may play a role in dissemination of
HHV-6.
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MDDCs infected with HHV-6 do not differentiate into macrophages or
mature
To investigate whether the characteristics of immature MDDCs are
altered byHHV-6B infection, we initially focused on the capacity of the
infected cells to differentiate and mature. We found that mock-
infectedMDDCs gradually changed theirmorphology from suspension
to adherent by 5 dpi, whereas HHV-6-infected cells did not (Figs. 1A
and B). Since immature MDDCs are known to differentiate into
macrophages upon the removal of stimulation with GM-CSF and IL-4,
we analyzed the expression level of the macrophage lineage marker
CD14 on the cell surface. As expected, although the CD14 level was
reduced during the course of differentiation into MDDCs, it was
reelevated by the removal of GM-CSF and IL-4 (mock, CD14 in Fig. 1C).
On the other hand, on the surface of HHV-6-infectedMDDCs, the CD14
level did not rise, even when the stimuli were removed (HHV-6, CD14
in Fig. 1C). Similar results were obtained for several adhesion
molecules: CD11b (Mac-1), CD54 (ICAM-1), integrin α2, integrin α5,
and integrin β5 (Fig. 1C). These results suggested that the further
differentiation of immature DCs was suppressed by HHV-6 infection.
We next examined whether the MDDCs underwent maturation in
response to HHV-6 infection. LPS- or poly(I:C)-treated MDDCs were
used as a positive control for DC maturation. As shown in Fig. 2,
although HHV-6-infected MDDCs produced low levels of the inﬂam-Fig. 1. Changes of morphology and expression of cell surface molecules were induced in mo
changes were found in mock-, but not HHV-6-infected cells at 3 days postinfection (dpi). (B)
ﬂask, and the cell number was counted separately. The proportion of adherent cell number
result is represented as the mean of three independent experiments. (C) FACS analysis for
incubated with each monoclonal antibody (MAb) for 30 min at room temperature (RT), and t
with FITC for 30 min at RT. MAbs for CD11b and CD54 were preconjugated with PE, and the a
and other molecules involved in cell adhesion were upregulated in the mock-infected MDDmatory cytokines IL-6, IL-8, IL-12p70 and TNF at 24 hpi (Fig. 2A) and
72 hpi (data not shown), the elevated levels were quite small when
compared to the cells treated with LPS or poly(I:C). In addition, the
expression level on the cell surface of CD86,which is a marker for
activated DCs, was upregulated by HHV-6 infection, but at low level
compared to LPS or poly(I:C) stimulation (Fig. 2B). Another marker for
mature DCs, CCR7, was not changed by HHV-6 infection. Taken
together, these data indicated that HHV-6 infection slightly induced
immature MDDCs to mature, but the effect was much weaker than
that of LPS and poly(I:C).
The viral antigens are expressed in MDDCs
There are two contradictory reports on HHV-6 replication in
MDDCs; one indicates that MDDCs are permissive for HHV-6
replication (Kakimoto et al., 2002), the other that they are not
(Smith et al., 2005). Therefore, to investigate viral replication in
MDDCs, we performed FACS analysis and real-time PCR. The FACS
analysis of HHV-6-infected MDDCs showed that HHV-6 early nuclear
antigen and gB were expressed at 5 dpi in 21% and 16% of the cells,
respectively (Fig. 3A), indicating that the infection with HHV-6 could
proceed to the late stage in more than 10% of the MDDCs. Although
over 80% of the cells were positive for viral glycoprotein B (gB)
immediately after infection (at 0 dpi), this signal was apparently from
virions captured on the MDDC surface (Fig. 3A). In addition, real-time
PCR showed that viral DNA amount in MDDCs were about 1000 copiesck-, but not HHV-6-infected MDDCs by removal of GM-CSF and IL-4. (A) Morphological
The suspension cells and adherent cells were separately collected from each cell culture
in total cell number (suspension and adherent cells) of each ﬂask was determined. The
cell-surface molecules on mock- and HHV-6-infected MDDCs at 5 dpi. Live cells were
he cells stained for integrins were then incubated with secondary antibodies conjugated
ntibody for CD14 was FITC-labeled. CD14, a lineage marker for monocytes/macrophages,
Cs.
Fig. 2.HHV-6 infection slightly induced immatureMDDCs tomature. (A) Multiplex assays using luminex systemwas performed tomeasure the production of inﬂammatory cytokines
in the culture supernatants of infected cells at 24 hpi. The result is represented as the mean of three independent experiments. (B) FACS analysis for the expression level of DC
activation markers, CD86 and CCR7. Live cells were labeled with an anti-CD86 FITC MAb or mouse anti-CCR7 MAb for 30 min at RT. Cells stained for CCR7 were then incubated with
secondary anti-mouse antibodies labeled with FITC for 30 min at RT. Either cytokines or cell-surface markers were elevated in the HHV-6-infected cells, but they were much weaker
than remarkable upregulation by treatment with LPS or poly(I:C), used as a positive control.
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constant at low level in the culture supernatant (Fig. 3B), indicating
that mature progeny virions may not be released from the cytoplasm,
may be trapped on the cell surface, or may not form in the cytoplasm
of HHV-6-infected MDDCs, even though viral late proteins are
certainly expressed in these cells.
Mature progeny virions are scarce in the cytoplasm of MDDCs infected
with HHV-6
To examine the virion maturation in MDDCs, an electron micro-
scopic examination of the virus-infected MDDCs was performed. As
shown in Fig. 4, many nucleocapsids were observed in the nucleus at
5 dpi, and the number of capsids with and without a DNA core (white
and black arrows, respectively) was almost the same (Fig. 4A). On the
other hand, virions were scarce in the cytoplasm of the infected cells.
In addition, small vacuoles inside the nucleus and the nuclear
membrane where enveloped nucleocapsids had accumulated were
observed (Fig. 4B).
HHV-6 is transmitted from MDDCs to CD4+ T cells
As demonstrated above, mature virions were scarce in the
cytoplasm of MDDCs. Therefore, we next asked whether, under such
conditions, viral transmission fromDCs to target cells occurs, as it does
for other viruses. To address this question, HHV-6-infected MDDCs at
5 dpi were cocultured with CD4+ T cells stimulated with PHA and IL-2
for 2 days, at a ratio of 1:5 for 4 days, and then FACS analysis and
TCID50 assays were performed to determine whether the HHV-6
replicated in the T cells. Fig. 5A shows that HHV-6 gB was expressed
mainly in the CD28-positive population, which is a T-cell marker, thus
indicating that HHV-6 was transmitted from DCs and replicated in T
cells. The TCID50 assay showed that, although infectious virus was not
found in the culture supernatant of the infectedMDDCs, it was presentin the supernatants of the cocultured cells. Moreover, the titer of virus
produced in the cocultured cells was higher than in HHV-6-infected T
cells alone (Fig. 5B). Because numerous virions appeared to be
captured on the MDDCs in the results shown in Fig. 3A, we next
sought to determine whether the transmitted virus was derived from
virions captured on the cell surface or from newly produced ones.
Treatment of HHV-6-infected MDDCs with phosphonoformic acid
(PFA), which is a viral replication blocker, reduced the amount of gB
expression in the virus-transmitted T cells compared with PFA-
untreated MDDCs (Fig. 5C), indicating that progeny virions synthe-
sized in MDDCs are transported to T cells.
The level of viral transmission is higher from DCs than from macrophages
Because macrophages are also peripheral sentinels awaiting
contact with microbes, they could be candidates for the initial cells
capturing and transmitting HHV-6 as well. To examine this possibility,
we obtained two types of macrophages, M-macrophages and GM-
macrophages, by treating monocytes with M-CSF and GM-CSF,
respectively. As shown in Fig. 6, when the HHV-6-infected macro-
phages were cocultured with T cells, the amount of viral transmission
wasmuch lower from theM-macrophages than from the DCs, andwas
even lower from the GM-macrophages (Fig. 6). Our ﬁndings suggest
that DCs are a novel transporter of HHV-6 to permissive cells, but that
macrophages are not important in this process.
Finally, we examined whether natural DCs directly isolated from
human blood are actually involved in the transmission of the virus toT
cells, by using myeloid DCs (MDCs) and plasmacytoid DCs (PDCs)
isolated directly from PBMCs. The efﬁciency of cell-to-cell transmis-
sion of HHV-6 from MDCs was similar to the level from MDDCs, and
the level from PDCs was only a little lower (Fig. 7). In addition, we
unexpectedly observed that HHV-6 was efﬁciently transmitted from
the culture supernatants of both types of DCs to T cells, indicating that
virion maturation occurs in both types of natural DCs. These results
Fig. 3. HHV-6 DNA replication and the expression of viral proteins were found in MDDCs. (A) FACS analysis for the expression of viral antigens. HHV-6-infected cells were ﬁxed with
chilled acetone for 20min at −20 °C and incubated in PBS containing 3% FCS for blocking, for 30min at RT. Cells were incubatedwith the ﬁrst MAb, OHV-2, for early nuclear antigen, or
OHV-3, for gB, for 30 min at RT. The cells were then incubated with an FITC-labeled secondary antibody for 30 min at RT. (B) Real-time PCR assay for intracellular and extracellular
viral DNA. The amount of viral DNA extracted from the infected cells or the culture medium was normalized to the number of cells. Real-time PCR was performed using the SYBR
Green method. The result is represented as the mean of three independent experiments.
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transmitted from DCs during natural course of infection.
Discussion
While dendritic cells (DCs) are known to be potent antigen-
presenting cells (APCs) that directly link the innate and the adaptive
immune systems in the body's response against microbes, recent
studies have indicated that DCs are also exploited by some viruses as
an initial site of infection; such viruses include human immunodeﬁ-
ciency virus type 1 (HIV-1) (Cameron et al., 1992; Pope et al., 1994),
measles virus (MV) (Fugier-Vivier et al.,1997), and some herpesviruses
such as varicella zoster virus (VZV) (Abendroth et al., 2001) and
cytomegalovirus (CMV) (Halary et al., 2002). The present study also
showed that monocyte-derived DCs (MDDCs) but not macrophages
efﬁciently transmitted HHV-6 to CD4+ T cells, which the virus infects
productively. Natural DCs, myeloid DCs (MDCs), and plasmacytoid DCs
(PDCs), were also able to produce viral progeny. Thus, DCs may play a
major role in the initial spread of HHV-6 as well. Both MDCs and PDCs
infected with HHV-6 could release infectious virus to culture media,
but MDDCs could not (Fig. 5B). The DCs isolated directly from blood,but not MDDCs may have functions for virus replication and
production. This will require further study.
There have been a number of studies on the relationship between
HHV-6 infection and DC alteration (Hirata et al., 2001; Kakimoto et al.,
2002; Niiya et al., 2004; Smith et al., 2005). Kakimoto et al. (2002)
suggested that HHV-6 induced phenotypic and functional alterations
in DCs, as well as DC maturation with productive viral infection. On
the other hand, Smith et al. (2005) showed that pre-exposure to HHV-
6 impaired the DC maturation driven by IFN-γ and LPS, independent
of viral replication. Here, we showed that HHV-6 DNA synthesis and
the expression of late viral antigens occurred in immature DCs, in
agreement with the former study. Furthermore, we found that late
viral antigens were expressed in DCs whose maturation was induced
by treatment with LPS. Although the reason for the discrepancy
between our data and the ﬁnding by Smith et al. is not yet known, the
virus strain or culture conditions for the DCs used in each study may
affect the results.
The conventional mechanism of DC migration to the lymph nodes
(LNs) is exploited by some viruses. Upon capturing a microbe,
immature DCs undergo a maturation process, which includes an
increase in their expression of adhesion molecules, and changes in
Fig. 4. Progeny virions were observed in the nucleus, but not in the cytoplasm of HHV-6-
infected MDDCs. At 5 dpi, MDDCs infected with HHV-6 were subjected to electron
microscopic analysis (HITACHI; H-7650). Empty and core DNA-containing capsids
(white and black arrows, respectively) were observed in the MDDC nucleus (A), and
small vacuoles inside the nucleus where enveloped nucleocapsids accumulated could
be seen (B). Mature or immature virions were rarely observed in the MDDC cytoplasm
(A and B). Scale bars represent 1.0 μm.
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CCR5 and CCR6, and the upregulation of CCR7. CCR7 is particularly
essential for the homing of DCs to LNs, where the CCR7 ligands, SLC
(CCL21) and MIP-3β (CCL19), are expressed (Gunn et al., 1999;
Robbiani et al., 2000; Saeki et al., 1999). HIV-1 has been shown to
induce DCs to upregulate their CCR7 expression(Wilﬂingseder et al.,
2004), which is advantageous for the virus' transport from the
mucosal area to the LNs and the establishment of infection in T cells.
Unlike with HIV-1, we did not see the upregulation of CCR7 in DCs
infected with HHV-6; therefore, a different mechanism is probably
used for HHV-6's transmission from DCs to T cells. Similar results have
been shown for Herpes simplex virus type 1 (HSV-1); i.e., HSV-1
infection inhibits DC maturation, and the infected cells fail to acquire
responsiveness to the CCR7 ligand ELC (Salio et al., 1999).
If the mucosal site initially targeted by HHV-6 is the tonsils, the
expression of CCR7 is necessary for the accumulation of DCs in T-cell-
rich areas of the tonsils as reported previously (Dieu et al., 1998).
Several hypotheses provide possible explanations for how the HHV-6-
infected DCs come to interact with Tcells. First, mature DCs expressing
CCR7 in the tonsils may capture and transport HHV-6 to the LNs. In
fact, we have obtained data showing that LPS-matured MDDCs
transmit HHV-6 to CD4+ T cells as efﬁciently as immature MDDCs
(data not shown). In addition, the HHV-6A-encoded viral chemokine
receptor U51 has been shown to bind a variety of human chemokines,
including MIP-3β (CCL19), a CCR7 ligand, and this receptor is thought
to mimic the function of CCR7 (Catusse et al., 2008). Therefore, a
second hypothesis is that HHV-6 U51, like CCR7, promotes themigration of infected DCs to LNs. Third, the chemoattraction of T
cells may be involved in the interaction between DCs and T cells via
cellular and/or viral chemokines. For example, HHV-6-encoded U83 is
a functional β-chemokine homolog that causes the chemotaxis of
leukocytes (Dewin et al., 2006; Zou et al., 1999).
Progeny viruses were not detected in the culturemedium of DCs by
virus titration, and few enveloped mature virions were observed in
the cytoplasm, although viral nucleocapsids were detected in the
nucleus of MDDCs by electron microscopy. We barely found viral
particles in intranuclear vesicles which were similar to ‘tegusomes’
termed and reported by Roffman et al. (1990). However, a consider-
able level of viral transmission fromMDDCs to T cells was observed. In
the case of HIV-1, viruses can be stored in an intracellular compart-
ment such as amultivesicular body until DCsmake contact with Tcells
(Garcia et al., 2005; Kwon et al., 2002; Wiley and Gummuluru, 2006),
but we could not observe any such compartments in the HHV-6-
infected MDDCs. In addition, treatment of the DCs with a blocker of
viral DNA replication reduced the transmission of virus from DCs to T
cells. These results show that the production of progeny virions is
required for this transmission.
The interaction between DCs and T cells induces many costimu-
latory signals in both cell types via the B7-CD28 family, and HIV-1 has
been found to upregulate the CD40 ligand on DCs while impairing the
DCs' intrinsic production of cytokines (Smed-Sorensen et al., 2004).
The molecular mechanisms induced in the HHV-6-infected MDDCs
after the DC-T-cell attachment, including which costimulating
molecules may be involved, remain to be elucidated.
In conclusion, this study shows that viral transmission occurs
efﬁciently from DCs to T cells, whereas there is little transmission
from monocyte-derived macrophages, indicating that the DCs may
be the ﬁrst cell population targeted by HHV-6 in vivo, and thus may
play an important role in transmitting the virus to T cells for further
propagation.
Materials and methods
Cell cultures
Monocytes were isolated from the peripheral blood mononuclear
cells (PBMCs) of healthy volunteers using CD14 microbeads (Miltenyi
Biotec). Monocytes were cultured in RPMI 1640 medium comple-
mented with 10% fetal calf serum (FCS) for 7 days in the presence of
800 U/ml GM-CSF (R&D Systems) and 400 U/ml IL-4 (R&D Systems)
to prepare monocyte-derived dendritic cells (MDDCs). M-macro-
phages and GM-macrophages were respectively obtained by stimu-
lating monocytes with 50 ng/ml M-CSF (R&D Systems) or 400 U/ml
GM-CSF for 7 days. Myeloid and plasmacytoid DCs were directly
isolated from PBMCs using a CD1c (BDCA-1)+ dendritic cell isolation
kit (Miltenyi Biotec) and CD304 (BDCA4/Neuropilin-1) microbead kit
(Miltenyi Biotec), respectively. CD4+ T cells isolated from PBMCs
using T cell isolation kit II (Miltenyi Biotec) were cultured for 2 days
in the presence or absence of IL-2 and PHA, and subjected to
experiments. The research was approved by the relevant institu-
tional ethics committees and all human participants gave written
informed consent.
Antibodies
Monoclonal antibodies (MAbs) OHV-1 and OHV-2, against HHV-6
antigens glycoprotein B (gB) and early nuclear protein, respectively,
were produced in our laboratory as described previously (Mori et al.,
2000; Okuno et al., 1992). The rabbit antiserum speciﬁc for HHV-6 gB
was prepared as follows. Rabbits were immunized ﬁve times with a
puriﬁed recombinant protein, named AgB-c. AgB-c was expressed as a
glutathione S-transferase (GST) fusion protein and puriﬁed with
glutathione sepharose 4B (GE Healthcare). To prepare the fusion
Fig. 5. HHV-6 was transmitted fromMDDCs toT cells. Allogeneic primary CD4+ T cells isolated from PBMCs and activated with PHA and IL-2 for 2 days were used as the target cells. At
5 dpi, HHV-6-infected MDDCs were cocultured with T cells at a ratio of 1:5 and maintained for 5 days. (A) FACS analysis for HHV-6 gB and CD28. The cocultured cells were ﬁxed with
chilled acetone for 20min at −20 °C and incubated in PBS containing 3% FCS for blocking, for 30min at RT. The cells were then incubated with a rabbit PAb against HHV-6 gB, and then
with a secondary anti-rabbit antibody labeled with FITC, and ﬁnally with an anti-CD28 MAb labeled with APC. Each incubation step was performed for 30 min at RT. (B) Titration of
the viral load by TCID50. After 5 days of infection, the culture supernatants were harvested from MDDCs or PHA/IL-2-stimulated primary CD4+ T cells infected with HHV-6 and
cultured for 5 days, or from stimulated T cells cocultured with HHV-6-infected MDDCs for 5 days, and subjected to determination of the TCID50. The result is represented as the mean
of three independent experiments. (C) MDDCs were infected with HHV-6 for 5 days in the presence or absence of a viral DNA synthesis blocker, and then coculturedwith stimulated T
cells after removal of the drug. The expression of gB in the cocultured cells was observed by FACS analysis to evaluate the transmission of HHV-6 to T cells.
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GATGTTG-3′) and AgBsalR (5′-ACCGTCGACTCACGCTTCTTCTA-
CATTTAC-3′; underlining indicates restriction enzyme site) were
used to amplify the insert from HHV-6A DNA. The expression vector
wasmade by inserting the PCR product into the prokaryotic expression
vector, pGEX-4T (GE Healthcare) at the BamHI and SalI sites. The
recombinant protein was expressed and puriﬁed. To label cell-surface
proteins directly, anti-CD14 FITC (130-080-701; Miltenyi Biotec), anti-
CD11b (Mac1) PE (347557; BD Biosciences), anti-CD28 APC (302912;
BioLegend), anti-CD54 (ICAM-1) PE (31625; Pharmingen), and anti-
CD86 FITC (33404; Pharmingen) MAbs were used. Integrins α2, α5
(611435; BD Biosciences), β5 (407316; Calbiochem), CCR7 (MAB197;
R&D Systems), and viral antigens were indirectly labeled by anti-
mouse FITC-conjugated secondary antibodies (F0479; DAKO).
Virus infection
HST is a strain of HHV-6 variant B (HHV-6B). The methods for
preparing viral stock from umbilical cord blood mononuclear cells
(CBMCs) and for infecting cells with this virus were described
previously (Akkapaiboon et al., 2004). Multiplicity of infection wasone for MDDC, macrophages, and CD4+ T cells, and three for MDC and
PDC. The 50% tissue-culture infective dose (TCID50) was determined
by the method of Reed and Muench, as described previously (Asada et
al., 1989).
Flow cytometry
Cells were incubated with antibodies (Abs) labeled with FITC or PE
for 1 h at room temperature (RT), washed twice, and analyzed by FACS
Canto (BD Biosciences). FITC-conjugated mouse monoclonal IgG
(Santa Cruz) was used as a control. To detect intracellular viral
antigens, HHV-6-infected cells were ﬁxed with cold acetone for
20 min at −20 °C, blocked with 3% FCS for 30 min at RT, and incubated
with primary Abs. After two washes, the ﬁxed cells were incubated
with an anti-mouse or anti-rabbit secondary antibody conjugated
with FITC, for 30 min at RT, and then subjected to FACS, as above.
Measurement of cytokines by microbeads assay
To assess the production of cytokines, the culture supernatant of
MDDCs exposed to HHV-6, LPS, or poly(I:C) was subjected to Bio-Plex
Fig. 6.HHV-6 transmission frommonocyte-derivedmacrophages toT cells was slight. Allogeneic primary CD4+ T cells isolated from PBMCs and activated with PHA and IL-2 for 2 days
were used as the target cells. Macrophages (Mø) induced with GM-CSF (GM–Mø) or M-CSF (M–Mø), or MDDCs infected with HHV-6 were cocultured with T cells at 5 dpi at a ratio of
1:5 and maintained for 5 days. The expression of gB in the cocultured cells was observed by FACS analysis to evaluate the HHV-6 transmission to T cells.
300 M. Takemoto et al. / Virology 385 (2009) 294–302suspension array system (Bio-Rad Laboratories) using antibody bead
kits of human IL-6, IL-8, IL-12p70, and TNF-alpha (Biosource Inc).
Electron microscopy
HHV-6-infected MDDCs were collected at 5 days post infection
(dpi) and were immediately ﬁxed for 2 h at 4 °C with 2.5%
glutaraldehyde and 4% paraformaldehyde in 50 mM sodium cacody-
late buffer (pH 7.4). Small pieces were postﬁxed in sodium cacodylate-
buffered 1.5% osmium tetroxide for 1 h at 4 °C, block stained in 0.5%Fig. 7. HHV-6 was transmitted frommyeloid (MDCs) and plasmacytoid DCs (PDCs) to T cells. A
2 days were used as the target cells. The T cells were cocultured with HHV-6-infected DCs at
After 5 days, viral transmission to T cells via cell-to-cell (cell–cell) or cell-free virus (sup) fruranyl acetate, dehydrated through a series of ethanol concentrations,
and embedded in Epon resin (TAAB). Ultrathin sections were stained
with uranyl acetate and lead citrate and examined under a Hitachi
electron microscope (H-7650).
Real-time PCR
For DNA extraction, cells or culture supernatants were ﬁrst treated
with K buffer (50mMKCl,10mMTris [pH8.2], 3mMMgCl2, 0.45% [v/v]
NP-40, 0.45% [v/v] Tween-20, and 100 μg/ml proteinase K) for 2 h atllogeneic primary CD4+ T cells isolated from PBMCs and activated with PHA and IL-2 for
a ratio of 5:1 for 5 days or inoculated with the culture supernatant of the infected DCs.
om the DCs was analyzed by FACS.
301M. Takemoto et al. / Virology 385 (2009) 294–30256 °C, and theDNAwas puriﬁed byextractionwith phenol/chloroform/
isoamylalcohol and precipitation with ethanol. For real-time PCR, the
DNA was ampliﬁed using the following primer set: IE1-4F (5′-
AGTCGGATCCGTGTTTACCATCCCAATAAGGTC-3′) and IE1-3R (5′-
AGTCCTCGAGGGTTGGTGTTATGACTCCCAAGTC-3′), for 45 cycles (20 s
at 95 °C, 20 s at 58 °C, and 30 s at 72 °C) on a MyiQ (Biorad) using
Platinum SYBR Green qPCR supermix-UDG (Invitrogen), according to
the manufacturer's recommendations. The number of genomic DNA
copies was determined using a standard curve (correlation coefﬁcient
of N0.995) created using a quantiﬁed DNA plasmid (pGEX-IE1-4) that
was constructed by inserting the ORF U89 sequence ampliﬁed with
IE1-4F and IE1-4R (5′-AGTCCTCGAGCAATTTACATCTTGGTTT-
CATCTAGC-3′) into the BamHI and XhoI sites.
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